Table 3. Summary of recurrence.
| Variables | NoMLE (%) | MLS (%) | MLND (%) | P value* |
|---|---|---|---|---|
| GGO-predominant | 0.871 | |||
| Overall recurrence | 1 (3.6) | 1 (5.3) | 3 (3.6) | |
| Locoregional | 0 | 0 | 1 (1.2) | |
| Distant | 0 | 0 | 1 (1.2) | |
| Both | 1 (3.6) | 1 (5.3) | 1 (1.2) | |
| Solid-predominant | 0.002 | |||
| Overall recurrence | 13 (46.4) | 11 (28.2) | 34 (21.0) | |
| Locoregional | 8 (28.6) | 5 (12.8) | 14 (8.6) | |
| Distant | 2 (7.1) | 2 (5.1) | 11 (6.8) | |
| Both | 3 (10.7) | 4 (10.3) | 9 (5.6) |
Locoregional: recurrence within ipsilateral hemithorax including pleura and mediastinal lymph node. *, comparison among the three groups. GGO, ground glass opacity; NoMLE, no mediastinal lymph node evaluation; MLS, mediastinal lymph node sampling; MLND, mediastinal lymph node dissection.